As examples MCC950 and OLT1177, block NLRP3 oligomerization by inhibiting ATP hydrolysis via the NACHT domain, which is pivotal for receptor oligomerization and anti-cancer effects (68). The gene discussed is NLRP3; the disease is cancer.